| Financial Year |
March 31 2023 |
| Monetary Funds |
1,113,078,338.78 |
| Held-for-trading Financial Assets |
140,265,397.26 |
| Notes Receivable |
127,441,234.84 |
| Accounts Receivable |
1,092,290,716.18 |
| Advances to Suppliers |
77,756,559.98 |
| Other Receivables |
114,571,554.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,890,339,203.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,011,021.85 |
| Total Current Assets |
4,865,811,492.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,669,335.18 |
| Fixed Assetes |
2,474,270,182.78 |
| Under-construction Projects |
439,991,752.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
453,245,694.88 |
| R&D expenses |
43,888,060.05 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,867,561.88 |
| Deferred Income Tax Assets |
136,692,622.65 |
| Other Non-Current Assets |
199,426,728.95 |
| Sub-Total of Non-Current Assets |
3,803,132,219.43 |
| Total Assets |
8,668,943,711.55 |
| Short-Term Loans |
825,926,280.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
471,923,852.00 |
| Accounts Payable |
1,379,988,549.48 |
| Accounts Received In Advance |
1,017,800.00 |
| Employee Compensation Payable |
129,731,313.31 |
| Taxes Payable |
33,236,042.02 |
| Interest Payable |
5,439,881.11 |
| Dividend Payable |
4,915,000.00 |
| Other payables |
92,832,286.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,748,289.16 |
| Other Current Liabilities |
55,224,593.16 |
| Sub-Total of Current Liabilities |
3,296,767,932.06 |
| Long-term Loans |
434,415,901.45 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
179,040,968.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,529,390.46 |
| Deferred Income Tax Liabilities |
24,853,106.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,190,076,535.49 |
| Total Liabilities |
4,486,844,467.55 |
| Paid-In Capital(Or Share Stock) |
899,370,910.00 |
| Capital Surplus |
1,829,623,842.30 |
| Surplus Reserve |
115,485,168.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
718,028,032.50 |
| Minority Stockholder's Interest |
620,730,794.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,561,368,449.40 |
| Owner's Equity（Stockholder's Equity） |
4,182,099,244.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,668,943,711.55 |
